The Canadian Cancer Society (CCS) is proud to launch a new funding program in support of cancer research across Canada. The Challenge grant program will support cancer research projects across the cancer continuum and across disciplines, with an ultimate goal of solving a problem (i.e. a ‘challenge’) in cancer that will be meaningful to people affected by or at risk of cancer.

Important dates:

• Abstract registrations due: July 28, 2021
• Full applications due: September 22, 2021
• Results announcement: January 2022
• Anticipated start date: January 1, 2022

Applications for up to $150,000 per year for 3 years will be accepted. The approximate funding envelope for this competition is $5.25M per year, or enough to fund at least 35 grants. Applications focused on breast cancer and prostate cancer are encouraged.

Women have been significantly impacted by the COVID-19 pandemic. Inequalities that existed before the pandemic have been made worse. The pandemic has also greatly affected jobs in service sectors, which employ larger numbers of women.

The Women’s Employment Readiness (WER) pilot program will fund organizations to provide and test pre-employment and skills development supports for women. Projects will also include working with employers to reduce barriers to employing women. Four groups of women will be targeted:

• racialized and/or Indigenous women
• women with disabilities
• women from the LGBTQ2 community
• women who have been out of the workforce for a long time

Projects must be national in scope. That is, they must serve participants in 2 or more provinces/territories. Projects can be regional in scope if they will serve participants located in Official Language Minority Communities.

Eligible organizations can apply for funding up to $2.5M per project, per year. All projects must end by March 31, 2023.

The Canadian Glycomics Network (GlycoNet) is a Network of Centres of Excellence with more than 160 research groups in 35 universities. The Network focuses on the role of glycans (carbohydrates) in health. Areas of focus are neurodegenerative diseases, infectious diseases, chronic diseases, in particular diabetes & obesity, genetic diseases involving errors in glycan metabolism, and cancer. Additional information about Network research can be found at www.glyconet.ca. Academia Sinica, Taiwan’s premier research institution, focuses on conducting ground-breaking research that advances the frontiers of knowledge, in glycoscience. Academia Sinica has more than 30 research groups in six institutes carrying out research in glycoscience. Additional information about Academia Sinica can be found at www.sinica.edu.tw/en. GlycoNet has formalized a partnership with Academia Sinica to co-fund collaborative research between the two entities that could lead to tangible deliverables by the end of the project. Tangible deliverables can include publications, patent applications, new analytical methods, drug candidates, disease treatment or diagnosis. Accordingly, this Request for Proposals seeks to fund projects that involve at least two groups, one in Canada and one in Taiwan. GlycoN

Intersectoral action refers to the ways that different groups and sectors of society work together to improve health and the conditions that shape health. Under the Intersectoral Action Fund, the Public Health Agency of Canada is seeking proposals for community-based projects that support collective action on the social determinants of health. Specifically, this solicitation will aim to build capacity for intersectoral action across three project Streams:

• Stream 1: Identify priority areas for collective action on social determinants of health and wellbeing

• Stream 2: Foster transformative partnerships to facilitate action on social determinants of health and wellbeing

• Stream 3: Build capacity to take action on social determinants of health and wellbeing

If your organization is working in one of the above areas, or if these are areas where you would like to undertake new work, we encourage you to apply. Applications from small organizations are welcome – organizations can apply for between $25,000 and $250,000 per project.

The deadline to submit an application for this funding opportunity is July 12, 2021 at 3:00pm EDT. If you are interested in applying to this funding opportunity, please email phac.cgc.solicitations-csc.aspc@canada.ca and reference “Intersectoral Action Fund” in the subject line to request an application package. Only Funding Requests using the template provided in the application package will be considered.

The Proof-of-Concept Grants program will favour those applications that focus on challenging new directions in research into Alzheimer’s disease and other dementias. The Proof-of-Concept Grant will support investigators with innovative, potentially high-risk, high-yield exploration into dementia research. The maximum amount awarded is $100,000; the grant can be held for a maximum of three (3) years.

The specific objectives of this funding opportunity are to advance knowledge and strategies on how to increase vaccine confidence in populations experiencing conditions of marginalization, Indigenous Peoples and/or populations who have historically been under-vaccinated, including how to address structural, contextual, intersectional and historical barriers to vaccination by:

1. Addressing knowledge gaps related to understanding the causes and contributing factors to lower vaccination confidence associated with COVID-19, and provide communities, healthcare providers, and public health and health system leaders with actionable evidence to improve vaccine confidence and uptake in clinical and/or community contexts; and
2. Designing, implementing and/or evaluating promising interventions to increase vaccine confidence, including a focus on which approaches are most effective, in which populations and contexts, and why (implementation science approach).

First Nations, Inuit and Métis including Urban Indigenous communities

For applications addressing vaccine confidence among Indigenous Peoples applicants are encouraged to use a distinctions-based approach and to identify structural, contextual, and historical barriers that explain inequities in uptake and inform strategies for meaningful and culturally safe solutions. Projects must prioritize First Nations, Inuit and Métis Peoples and communities, including Urban Indigenous communities, in leading their own research, and include an approach based on Indigenous knowledge systems.

Applicants whose proposed research will involve Indigenous Peoples should consult the Tri-Council Policy Statement (TCPS 2 - Chapter 9 Research Involving the First Nations, Inuit and Métis Peoples of Canada) for guidance on research design.

The FY21 Defense Appropriations Act provides funding to the Department of Defense Duchenne Muscular Dystrophy Research Program (DMDRP) to support research addressing Duchenne pathobiology and discovery and development of therapeutics, related devices and tools. The managing agent for the anticipated program announcements/funding opportunities is the Congressionally Directed Medical Research Programs (CDMRP) at the U.S. Army Medical Research and Development Command (USAMRDC).

The FY21 DMDRP program announcements and General Application Instructions for the following award mechanisms are posted on the Grants.gov website.    

https://cdmrp.army.mil/funding/dmdrp

Idea Development Award – Preproposal due August 11, 2021

Translational Research Award - New for FY21 – Preproposal due August 11, 2021

A pre-application is required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) at https://eBRAP.org prior to the pre-application deadline.  All applications must conform to the final program announcements and General Application Instructions available for electronic downloading from the Grants.gov website.  The application package containing the required forms for each award mechanism will also be found on Grants.gov.  A listing of all CDMRP and other USAMRDC extramural funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420. 

For email notification when program announcements are released, subscribe to program-specific news and updates under “Email Subscriptions” on the eBRAP homepage at https://eBRAP.org.  For more information about the DMDRP or other CDMRP-administered programs, please visit the CDMRP website (https://cdmrp.army.mil).

Point of Contact:

CDMRP Help Desk
301-682-5507
help@eBrap.org